JMP Securities Starts Aquestive Therapeutics (AQST) at Market Outperform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to JMP Securities Starts Aquestive Therapeutics (AQST) at Market Outperform

RBC Capital Starts Aquestive Therapeutics (AQST) at Outperform

August 20, 2018 8:07 AM EDT

RBC Capital analyst Randall Stanicky initiates coverage on Aquestive Therapeutics (NASDAQ: AQST) with an Outperform rating and a price target of $23.00.

Stanicky said with stable cash flows from Suboxone behind it and a broad pipeline ahead of it, AQST is well... More

BMO Capital Starts Aquestive Therapeutics (AQST) at Outperform

August 20, 2018 5:15 AM EDT

BMO Capital analyst Gary Nachman initiates coverage on Aquestive Therapeutics (NASDAQ: AQST) with a Outperform rating and a price target of $26.00.

The analyst comments "AQST has best in-class PharmFilm drug delivery technology and a proven track record developing a robust portfolio of... More